Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Retrograde transvenous perfusion.

J G Frazee1, X Luo

  • 1Division of Neurosurgery, University of California Los Angeles, School of Medicine, USA.

Critical Care Clinics
|November 24, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dual-functional lipid-like nanoparticles for delivery of mRNA and MRI contrast agents.

Nanoscale·2017
Same author

Intrinsic Ferromagnetism in the Diluted Magnetic Semiconductor Co:TiO_{2}.

Physical review letters·2016
Same author

Poly(glycoamidoamine) brush nanomaterials for systemic siRNA delivery in vivo.

Biomaterials science·2016
Same author

Association between the PPARγ Pro12Ala polymorphism and risk of gestational diabetes mellitus: a meta-analysis.

Genetics and molecular research : GMR·2016
Same author

Recurrent IgA Nephropathy After Kidney Transplantation.

Transplantation proceedings·2016
Same author

Rapamycin protects against neuronal death and improves neurological function with modulation of microglia after experimental intracerebral hemorrhage in rats.

Cellular and molecular biology (Noisy-le-Grand, France)·2016
Same journal

Critical Care and Contagion: Evolving Frontiers of Infectious Diseases in the Modern Intensive Care Unit.

Critical care clinics·2026
Same journal

Advances and Challenges in Sepsis Care in Low-Resource Settings.

Critical care clinics·2026
Same journal

The Respiratory Triple Pandemic in the Intensive Care Unit: Epidemiology, Clinical Features and Management of COVID-19, Influenza and Respiratory Syncytial Virus.

Critical care clinics·2026
Same journal

Antibiotic Stewardship for the Intensivist.

Critical care clinics·2026
Same journal

Infection Prevention and Control in the Intensive Care Unit.

Critical care clinics·2026
Same journal

Antibiotic Considerations in the Critically Ill: Empiric Choices and Dosing.

Critical care clinics·2026
See all related articles

This study introduces retrograde transvenous neuroperfusion, a novel stroke treatment using the patient's own blood. This innovative therapy shows promise in preventing and reversing ischemic brain injury, potentially enhanced with hypothermia.

Area of Science:

  • Neurology
  • Vascular Surgery
  • Regenerative Medicine

Background:

  • Stroke poses significant health challenges, necessitating advanced treatment strategies.
  • Current stroke therapies have limitations, driving research into novel approaches.
  • Ischemic brain injury requires immediate and effective interventions.

Purpose of the Study:

  • To investigate a new method for treating stroke: retrograde transvenous neuroperfusion.
  • To evaluate the efficacy of this neuroperfusion technique in preclinical and clinical settings.
  • To explore the potential synergistic effects of combining neuroperfusion with hypothermia.

Main Methods:

  • Developed a technique to perfuse arterial blood retrogradely through the venous system to ischemic brain areas.

Related Experiment Videos

  • Conducted laboratory experiments to assess the therapeutic benefits.
  • Performed a small-scale clinical trial to evaluate safety and preliminary efficacy.
  • Investigated the combination of retrograde transvenous neuroperfusion and hypothermia.
  • Main Results:

    • The retrograde transvenous neuroperfusion method demonstrated success in preventing and reversing ischemic brain injury in laboratory models.
    • Preliminary results from a small clinical trial indicate the treatment's potential benefit.
    • Laboratory studies suggest that combining this therapy with hypothermia may enhance its effectiveness.

    Conclusions:

    • Retrograde transvenous neuroperfusion is a promising new therapeutic strategy for stroke.
    • The technique has shown efficacy in both experimental and early clinical settings.
    • Further research into the combination of neuroperfusion and hypothermia is warranted to optimize stroke treatment.